University of Southern California: Prostatic Neoplasms trials

The registry lists 36 Prostatic Neoplasms studies with University of Southern California as lead sponsor. 4 are open to participants now and 5 have results posted.

Phase 1 5Phase 2 12No phase 21(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER TrialRecruitingNCT07162194Not applicable
• Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer SurvivorsRecruitingNCT06500169Not applicable
• Access to Genetic Testing in Underserved Patients With CancerRecruitingNCT06422455Not applicable
• Longitudinal Advanced Prostate Cancer Cohort (LAPCC)RecruitingNCT06067295
• Prostate Resection After Microwave Ablation (PRAMA)CompletedNCT06128525Not applicableResults posted
• Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate CancerCompletedNCT02217709Phase 2Results posted
• Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate CancerTerminatedNCT01866423Phase 2Results posted
• Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate CancerCompletedNCT01338792Phase 2Results posted
• Study of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate CancerTerminatedNCT00183937Phase 2Results posted
• Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)CompletedNCT07568444Phase 2
• Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate CancerSuspendedNCT04981834Not applicable
• Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation TherapyTerminatedNCT04927559
• An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prostate CancerCompletedNCT04318028Not applicable
• High-Intensity Focused Ultrasound in Treating Participants With Intermediate and High-risk Prostate CancerWithdrawnNCT03514927Not applicable
• Collection of Blood in Studying Metabolites in Patients With Prostate CancerTerminatedNCT03485794
• Social Media Listening in Improving Clinical Trial Recruitment in Patients With CancerWithdrawnNCT03408561Not applicable
• Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate CancerActive, not recruitingNCT03344211Phase 2
• Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer SurvivorsTerminatedNCT03284346Not applicable
• Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer PatientsTerminatedNCT02853097
• 18F-FMAU PET/CT in Diagnosing and Characterizing Prostate CancerTerminatedNCT02809690Phase 1
• sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney CancerTerminatedNCT02767921Phase 1
• Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid TumorsActive, not recruitingNCT02717156Phase 2
• Hypofractionated Stereotactic Body Radiation Therapy for Patients With Prostate Cancer That Was Removed by SurgeryStatus unknownNCT02446366Not applicable
• Molecular Characterization of CTCs and ctDNA in Blood and Plasma Samples From Patients With Metastatic and/or Hormone-Resistant Prostate CancerTerminatedNCT02370355
• Diffusion-Weighted MRI in Staging Patients With Localized Prostate CancerCompletedNCT02237612Not applicable
• Resistance Training and Protein Supplementation for Prostate Cancer SurvivorsCompletedNCT01909440Not applicable
• Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate CancerActive, not recruitingNCT01802346Not applicable
• Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Image-Guided Prostate Biopsy Following Radical Prostatectomy in Patients With Prostate CancerCompletedNCT01764347Not applicable
• Abiraterone Acetate and Prednisone With or Without Dasatinib in Treating Patients With Metastatic Hormone-Resistant Prostate CancerStatus unknownNCT01685125Phase 2
• Transrectal Ultrasound (TRUS) in Finding Tumors During Robotic-Assisted Laparoscopic SurgeryCompletedNCT01495130Not applicable
• Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With DocetaxelTerminatedNCT01469338Phase 2
• Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate CancerCompletedNCT01240629Phase 1/2
• Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT01155258Phase 1
• Herbal Therapy for Treatment of Recurrent Prostate CancerCompletedNCT00669656Phase 2
• Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate CancerCompletedNCT00574769Phase 1/2
• FDG Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate CancerCompletedNCT00282906Not applicable